Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma - Venous Thromboembolism
Conditions: official terms
Carcinoma - Carcinoma, Non-Small-Cell Lung - Lung Neoplasms - Thromboembolism - Venous Thromboembolism - Venous Thrombosis
Conditions: Keywords
Lung cancer, Thrombosis, Hypercoagulable
Study Type
Study Phase
Study Design
Primary Purpose: Screening, Time Perspective: Longitudinal
Name: Blood sample withdrawal
Type: Procedure
Overall Status
The association between cancer and thrombosis is well known and the occurrence of thrombotic complications is commonly associated with poor prognosis. The aim os this study is to determine the possible value of hypercoagulable parameters as prognostic parameters in advanced non-small cell lung carcinoma (NSCLC).
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: N/A
Gender: Both
Criteria: Inclusion Criteria:

- Histologically or cytologically confirmed diagnosis of NSCLC.

- normal serum bilirubin

- informed concent to participate in the study

Exclusion Criteria:

- anticoagulant therapy

- infectious disease
Hematology Laboratory
Haifa, Israel
Status: Recruiting
Contact: Galit Sarig, Ph.D - +972-4-8543523 - g_sarig@rambam.health.gov.il
Oncology Institution, Rambam Health Campus
Haifa, Israel
Status: Recruiting
Contact: Nissim Haim, M.D - n_haim@rambam.health.gov.il
Start Date
June 2005
Rambam Health Care Campus
Rambam Health Care Campus
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page